Tracking antibiotic resistance in the DRC
Part of Infections clinical trials.
This study looks for antibiotic-resistant bacteria in the blood of patients with a suspected bloodstream infection. The goal is to understand which antibiotics still work, helping doctors choose the right treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 6 months.
- You have a bloodstream infection suspected by a doctor at the hospital.
- You just arrived at the hospital or have been there for less than 2 days.
- You (or your guardian) can give permission to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new, faster way to choose the right antibiotic for people with a blood infection caused by Enterobacterales bacteria. The goal is to see if this quick test helps doctors start the most effective treatment sooner.
This study is looking at how to better care for people with fever in the Democratic Republic of the Congo. If you have a fever now or very recently, you may be able to join and help doctors learn more about it.
This trial looks at different ways to control mosquitoes that spread diseases. It will see how well these methods work in households and health facilities in Kinshasa.
This study is testing a new rapid test for plague, a serious infection. It aims to see if the test can quickly spot plague in people with symptoms, helping them get the right treatment sooner.
This study looks at the types of drug-resistant tuberculosis (TB) bacteria spreading in Central Africa. By examining sputum samples from people with TB, researchers hope to better understand how resistant strains are transmitted, which can help improve treatment.
This study collects and studies lab-detected germs in hospital patients that produce special enzymes making some antibiotics less effective. It helps researchers understand how these resistant germs spread over time in Switzerland.
Hear when a new Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.